Paediatric genitourinary cancers and late effects of treatment

被引:16
作者
Sadak, Karim T. [1 ]
Ritchey, Michael L. [2 ]
Dome, Jeffrey S. [1 ]
机构
[1] Childrens Natl Med Ctr, Div Oncol, Washington, DC 20010 USA
[2] Phoenix Childrens Hosp, Dept Surg, Phoenix, AZ 85016 USA
关键词
GERM-CELL TUMORS; HISTOLOGY WILMS-TUMOR; CHILDHOOD-CANCER; FERTILITY PRESERVATION; ADOLESCENT CANCER; PELVIC RHABDOMYOSARCOMA; MALIGNANT NEOPLASMS; OVARIAN TISSUE; DOSE CISPLATIN; LATE MORTALITY;
D O I
10.1038/nrurol.2012.218
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The most common childhood genitourinary cancers are Wilms tumour, rhabdomyosarcoma and germ cell tumour (GCT). Long-term survival rates for patients with these tumours are generally excellent, ranging from 80% to 100%. However, the high cure rates have highlighted the need to minimize the long-term complications of treatments (referred to as 'late effects'), which can be caused by the three treatment modalities used to treat genitourinary tumours: surgery, chemotherapy and radiation therapy. Serious late effects, such as death, second cancers and tumour recurrence, are uncommon but do occur occasionally. Chronic health conditions-such as cardiac, pulmonary and fertility disorders-are more prevalent. Given the high prevalence of late effects, survivors of childhood genitourinary malignancies require regular surveillance and health promotion delivered by health-care providers with specialist knowledge of the long-term complications of treatment. Sadak, K. T. et al. Nat. Rev. Urol. 10, 15-25 (2013); published online 27 November 2012; doi:10.1038/nrurol.2012.218
引用
收藏
页码:15 / 25
页数:11
相关论文
共 62 条
[1]   Transitional cell carcinoma of the urinary bladder following exposure to cyclophosphamide in childhood [J].
Agarwala, S ;
Hemal, AK ;
Seth, A ;
Gupta, AK ;
Bhatnagar, V ;
Mitra, DK .
EUROPEAN JOURNAL OF PEDIATRIC SURGERY, 2001, 11 (03) :207-210
[2]   Does bladder preservation (as a surgical principle) lead to retaining bladder function in bladder/prostate rhabdomyosarcoma? Results from Intergroup Rhabdomyosarcoma Study IV [J].
Arndt, C ;
Rodeberg, D ;
Breitfeld, PP ;
Raney, RB ;
Ullrich, F ;
Donaldson, S .
JOURNAL OF UROLOGY, 2004, 171 (06) :2396-2403
[3]  
Arndt CAS, 2001, CANCER, V91, P2454, DOI 10.1002/1097-0142(20010615)91:12<2454::AID-CNCR1281>3.0.CO
[4]  
2-C
[5]   Risk of selected subsequent carcinomas in survivors of childhood cancer: A report from the childhood cancer survivor study [J].
Bassal, M ;
Mertens, AC ;
Taylor, L ;
Neglia, JP ;
Greffe, BS ;
Hammond, S ;
Ronckers, CM ;
Friedman, DL ;
Stovall, M ;
Yasui, YY ;
Robison, LL ;
Meadows, AT ;
Kadan-Lottick, NS .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (03) :476-483
[6]  
Bath LE, 2002, BJOG-INT J OBSTET GY, V109, P107, DOI 10.1016/S1470-0328(02)01007-8
[7]  
Bernstein L., 1999, CANC INCIDENCE SURVI, P125
[8]  
BRESLOW N, 1988, CANCER RES, V48, P1653
[9]   2ND MALIGNANT NEOPLASMS FOLLOWING TREATMENT FOR WILMS-TUMOR - A REPORT FROM THE NATIONAL WILMS-TUMOR STUDY-GROUP [J].
BRESLOW, NE ;
TAKASHIMA, JR ;
WHITTON, JA ;
MOKSNESS, J ;
DANGIO, GJ ;
GREEN, DM .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :1851-1859
[10]   Secondary malignant neoplasms after Wilms tumor: an international collaborative study [J].
Breslow, Norman E. ;
Lange, Jane M. ;
Friedman, Debra L. ;
Green, Daniel M. ;
Hawkins, Mike M. ;
Murphy, Michael F. G. ;
Neglia, Joseph P. ;
Olsen, Jorgen H. ;
Peterson, Susan M. ;
Stiller, Charles A. ;
Robison, Leslie L. .
INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (03) :657-666